These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 10592434)
1. Granulocyte colony-stimulating factor on the growth of human ovarian carcinoma cells in vitro. Chao K; Chang C; Yen M; Wang P; Ng H Gynecol Obstet Invest; 1999; 48(4):280-4. PubMed ID: 10592434 [TBL] [Abstract][Full Text] [Related]
2. In vitro growth effects of colony-stimulating factors in ovarian cancer. Connor JP; Squatrito RC; Terrell KL; Antisdel BJ; Buller RE Gynecol Oncol; 1994 Mar; 52(3):347-52. PubMed ID: 7512521 [TBL] [Abstract][Full Text] [Related]
3. c-jun expression and growth stimulation in human ovarian carcinoma cell lines following exposure to cytokines. Spinner DM; Brandstetter T; Kiechle-Schwarz M; Du Bois A; Angel P; Bauknecht T Int J Cancer; 1995 Nov; 63(3):423-7. PubMed ID: 7591243 [TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients. Gay AN; Chang S; Rutland L; Yu L; Byeseda S; Naik-Mathuria B; Cass DL; Russell H; Olutoye OO J Pediatr Surg; 2008 May; 43(5):837-42. PubMed ID: 18485949 [TBL] [Abstract][Full Text] [Related]
5. Constitutive production of colony-stimulating factors by human hepatoma cell lines: possible correlation with cell differentiation. Wang SY; Chen LY; Tsai TF; Su TS; Choo KB; Ho CK Exp Hematol; 1996 Feb; 24(3):437-44. PubMed ID: 8599973 [TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [TBL] [Abstract][Full Text] [Related]
7. [The growth effect of granulocyte colony-stimulating factors on ovarian carcinoma cell lines]. Wu N; Cui H; Qian H Zhonghua Fu Chan Ke Za Zhi; 1999 Mar; 34(3):168-71. PubMed ID: 11263190 [TBL] [Abstract][Full Text] [Related]
8. Sequential granulocyte colony-stimulating factor increases cisplatin cytotoxicity in human epithelial ovarian cancer cell lines. Fanning J; Hilgers RD; Kane C; Medrano C Gynecol Oncol; 1996 Mar; 60(3):450-3. PubMed ID: 8774656 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of pro‑ and anti‑tumor effects induced by three colony‑stimulating factors, G‑CSF, GM‑CSF and M‑CSF, in bladder cancer cells: Is G‑CSF a friend of bladder cancer cells? Hori S; Miyake M; Onishi S; Morizawa Y; Nakai Y; Tatsumi Y; Onishi K; Iida K; Gotoh D; Itami Y; Tanaka N; Fujimoto K Int J Oncol; 2019 Jun; 54(6):2237-2249. PubMed ID: 31081057 [TBL] [Abstract][Full Text] [Related]
10. Growth modulatory effects of granulocyte-macrophage colony-stimulating factor on human cell lines derived from gynecologic malignancies. Herzog TJ; Horiuchi TK; Williams S; Camel HM; Mutch DG Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):161-8. PubMed ID: 8572001 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow cell mobilization by the systemic use of granulocyte colony-stimulating factor (GCSF) improves wound bed preparation. Iwamoto S; Lin X; Ramirez R; Carson P; Fiore D; Goodrich J; Yufit T; Falanga V Int J Low Extrem Wounds; 2013 Dec; 12(4):256-64. PubMed ID: 24275756 [TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Sloand EM; Yong AS; Ramkissoon S; Solomou E; Bruno TC; Kim S; Fuhrer M; Kajigaya S; Barrett AJ; Young NS Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14483-8. PubMed ID: 16980411 [TBL] [Abstract][Full Text] [Related]
13. [Effects of mifepristone on the proliferation, apoptosis, and cis-platinum (DDP) sensitivity of chemo-resistant human ovarian cancer cells]. Wang G; Zheng WT; Xiao P; Li XJ; Lin TC; Li GY Ai Zheng; 2004 Apr; 23(4):406-11. PubMed ID: 15087028 [TBL] [Abstract][Full Text] [Related]
14. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth of human ovarian cancer in nude mice by luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75). Manetta A; Gamboa-Vujicic G; Paredes P; Emma D; Liao S; Leong L; Asch B; Schally A Fertil Steril; 1995 Feb; 63(2):282-7. PubMed ID: 7843432 [TBL] [Abstract][Full Text] [Related]
19. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor increases tumor growth and angiogenesis directly by promoting endothelial cell function and indirectly by enhancing the mobilization and recruitment of proangiogenic granulocytes. Zheng Q; Li X; Cheng X; Cui T; Zhuo Y; Ma W; Zhao X; Zhao P; Liu X; Feng W Tumour Biol; 2017 Feb; 39(2):1010428317692232. PubMed ID: 28240048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]